細胞・先端治療サプライチェーン管理の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Cell and Advanced Therapies Supply Chain Management Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02578 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、細胞・先端治療サプライチェーン管理の世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞・先端治療サプライチェーン管理の種類別市場規模（クラウド、オンプレミス）、用途別市場規模（バイオバンク、細胞治療研究所、病院、研究所、商業組織）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Be The Match BioTherapies、MAK-SYSTEM、Cryoport、Brooks Life Sciences、Lykan Bioscience、Clarkston Consulting、SAP、Hypertrust Patient Data Care、Haemonetics、MasterControl、TraceLink、SAVSU Technologies、TrakCel、Title21 Health Solutions、sedApta Group、Vineti、Stafa Cellular Therapy ・地域別グローバル市場分析 2015年-2020年 ・細胞・先端治療サプライチェーン管理の北米市場（アメリカ、カナダ、メキシコ） ・細胞・先端治療サプライチェーン管理のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・細胞・先端治療サプライチェーン管理のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・細胞・先端治療サプライチェーン管理の南米市場（ブラジル、アルゼンチン） ・細胞・先端治療サプライチェーン管理の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：クラウド、オンプレミス ・用途別分析：バイオバンク、細胞治療研究所、病院、研究所、商業組織 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Cell and Advanced Therapies Supply Chain Management market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Cell and Advanced Therapies Supply Chain Management sales will be xx in 2020 from Cell and Advanced Therapies Supply Chain Management million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cell and Advanced Therapies Supply Chain Management market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Cell and Advanced Therapies Supply Chain Management industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cell and Advanced Therapies Supply Chain Management and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Cell and Advanced Therapies Supply Chain Management market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cell and Advanced Therapies Supply Chain Management market has been segmented into:
Cloud
On-premises

By Application, Cell and Advanced Therapies Supply Chain Management has been segmented into:
Biobank
Cell Therapy Lab
Hospital
Research Institute
Commercial Organization

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell and Advanced Therapies Supply Chain Management market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell and Advanced Therapies Supply Chain Management markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell and Advanced Therapies Supply Chain Management market.

The report offers in-depth assessment of the growth and other aspects of the Cell and Advanced Therapies Supply Chain Management market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Cell and Advanced Therapies Supply Chain Management Market Share Analysis
Cell and Advanced Therapies Supply Chain Management competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell and Advanced Therapies Supply Chain Management sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell and Advanced Therapies Supply Chain Management sales, revenue and market share for each player covered in this report.

The major players covered in Cell and Advanced Therapies Supply Chain Management are:
Be The Match BioTherapies
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Lykan Bioscience
Clarkston Consulting
SAP
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Among other players domestic and global, Cell and Advanced Therapies Supply Chain Management market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Cell and Advanced Therapies Supply Chain Management Market Overview
1.1 Product Overview and Scope of Cell and Advanced Therapies Supply Chain Management
1.2 Classification of Cell and Advanced Therapies Supply Chain Management by Type
1.2.1 Global Cell and Advanced Therapies Supply Chain Management Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type in 2019
1.2.3 Cloud
1.2.4 On-premises
1.3 Global Cell and Advanced Therapies Supply Chain Management Market by Application
1.3.1 Overview: Global Cell and Advanced Therapies Supply Chain Management Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biobank
1.3.3 Cell Therapy Lab
1.3.4 Hospital
1.3.5 Research Institute
1.3.6 Commercial Organization
1.4 Global Cell and Advanced Therapies Supply Chain Management Market by Regions
1.4.1 Global Cell and Advanced Therapies Supply Chain Management Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell and Advanced Therapies Supply Chain Management (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell and Advanced Therapies Supply Chain Management Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell and Advanced Therapies Supply Chain Management Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell and Advanced Therapies Supply Chain Management Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell and Advanced Therapies Supply Chain Management Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell and Advanced Therapies Supply Chain Management Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Cell and Advanced Therapies Supply Chain Management Industry Impact
1.5.1 COVID-19 Potential Implications for the Cell and Advanced Therapies Supply Chain Management
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cell and Advanced Therapies Supply Chain Management
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Be The Match BioTherapies SWOT Analysis
2.1.4 Be The Match BioTherapies Product and Services
2.1.5 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.2 MAK-SYSTEM
2.2.1 MAK-SYSTEM Details
2.2.2 MAK-SYSTEM Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MAK-SYSTEM SWOT Analysis
2.2.4 MAK-SYSTEM Product and Services
2.2.5 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cryoport
2.3.1 Cryoport Details
2.3.2 Cryoport Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cryoport SWOT Analysis
2.3.4 Cryoport Product and Services
2.3.5 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.4 Brooks Life Sciences
2.4.1 Brooks Life Sciences Details
2.4.2 Brooks Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Brooks Life Sciences SWOT Analysis
2.4.4 Brooks Life Sciences Product and Services
2.4.5 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lykan Bioscience
2.5.1 Lykan Bioscience Details
2.5.2 Lykan Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Lykan Bioscience SWOT Analysis
2.5.4 Lykan Bioscience Product and Services
2.5.5 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.6 Clarkston Consulting
2.6.1 Clarkston Consulting Details
2.6.2 Clarkston Consulting Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Clarkston Consulting Product and Services
2.6.4 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.7 SAP
2.7.1 SAP Details
2.7.2 SAP Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SAP Product and Services
2.7.4 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hypertrust Patient Data Care
2.8.1 Hypertrust Patient Data Care Details
2.8.2 Hypertrust Patient Data Care Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hypertrust Patient Data Care Product and Services
2.8.4 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.9 Haemonetics
2.9.1 Haemonetics Details
2.9.2 Haemonetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Haemonetics Product and Services
2.9.4 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.10 MasterControl
2.10.1 MasterControl Details
2.10.2 MasterControl Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MasterControl Product and Services
2.10.4 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.11 TraceLink
2.11.1 TraceLink Details
2.11.2 TraceLink Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 TraceLink Product and Services
2.11.4 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.12 SAVSU Technologies
2.12.1 SAVSU Technologies Details
2.12.2 SAVSU Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 SAVSU Technologies Product and Services
2.12.4 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.13 TrakCel
2.13.1 TrakCel Details
2.13.2 TrakCel Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 TrakCel Product and Services
2.13.4 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.14 Title21 Health Solutions
2.14.1 Title21 Health Solutions Details
2.14.2 Title21 Health Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Title21 Health Solutions Product and Services
2.14.4 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.15 sedApta Group
2.15.1 sedApta Group Details
2.15.2 sedApta Group Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 sedApta Group Product and Services
2.15.4 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.16 Vineti
2.16.1 Vineti Details
2.16.2 Vineti Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Vineti Product and Services
2.16.4 Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
2.17 Stafa Cellular Therapy
2.17.1 Stafa Cellular Therapy Details
2.17.2 Stafa Cellular Therapy Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Stafa Cellular Therapy Product and Services
2.17.4 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell and Advanced Therapies Supply Chain Management Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell and Advanced Therapies Supply Chain Management Players Market Share
3.2.2 Top 10 Cell and Advanced Therapies Supply Chain Management Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell and Advanced Therapies Supply Chain Management Revenue and Market Share by Regions
4.2 North America Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
4.3 Europe Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
4.5 South America Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
5 North America Cell and Advanced Therapies Supply Chain Management Revenue by Countries
5.1 North America Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
5.2 USA Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
5.3 Canada Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
6 Europe Cell and Advanced Therapies Supply Chain Management Revenue by Countries
6.1 Europe Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
6.2 Germany Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
6.3 UK Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
6.4 France Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
6.5 Russia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
6.6 Italy Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue by Countries
7.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
7.2 China Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
7.3 Japan Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
7.4 Korea Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
7.5 India Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
8 South America Cell and Advanced Therapies Supply Chain Management Revenue by Countries
8.1 South America Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
8.2 Brazil Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell and Advanced Therapies Supply Chain Management by Countries
9.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
9.3 UAE Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell and Advanced Therapies Supply Chain Management Revenue and Market Share by Type (2015-2020)
10.2 Global Cell and Advanced Therapies Supply Chain Management Market Forecast by Type (2019-2024)
10.3 Cloud Revenue Growth Rate (2015-2025)
10.4 On-premises Revenue Growth Rate (2015-2025)
11 Global Cell and Advanced Therapies Supply Chain Management Market Segment by Application
11.1 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2015-2020)
11.2 Cell and Advanced Therapies Supply Chain Management Market Forecast by Application (2019-2024)
11.3 Biobank Revenue Growth (2015-2020)
11.4 Cell Therapy Lab Revenue Growth (2015-2020)
11.5 Hospital Revenue Growth (2015-2020)
11.6 Research Institute Revenue Growth (2015-2020)
11.7 Commercial Organization Revenue Growth (2015-2020)
12 Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast (2021-2025)
12.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast (2021-2025)
12.2 Global Cell and Advanced Therapies Supply Chain Management Market Forecast by Regions (2021-2025)
12.3 North America Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
12.4 Europe Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
12.6 South America Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Cell and Advanced Therapies Supply Chain Management Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell and Advanced Therapies Supply Chain Management by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell and Advanced Therapies Supply Chain Management Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cell and Advanced Therapies Supply Chain Management Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Be The Match BioTherapies Corporate Information, Location and Competitors
Table 7. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Major Business
Table 8. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 9. Be The Match BioTherapies SWOT Analysis
Table 10. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 11. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. MAK-SYSTEM Corporate Information, Location and Competitors
Table 13. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Major Business
Table 14. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2018-2019)
Table 15. MAK-SYSTEM SWOT Analysis
Table 16. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 17. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Cryoport Corporate Information, Location and Competitors
Table 19. Cryoport Cell and Advanced Therapies Supply Chain Management Major Business
Table 20. Cryoport Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 21. Cryoport SWOT Analysis
Table 22. Cryoport Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 23. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Brooks Life Sciences Corporate Information, Location and Competitors
Table 25. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Major Business
Table 26. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 27. Brooks Life Sciences SWOT Analysis
Table 28. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 29. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Lykan Bioscience Corporate Information, Location and Competitors
Table 31. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Major Business
Table 32. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 33. Lykan Bioscience SWOT Analysis
Table 34. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 35. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Clarkston Consulting Corporate Information, Location and Competitors
Table 37. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Major Business
Table 38. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 39. Clarkston Consulting SWOT Analysis
Table 40. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 41. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. SAP Corporate Information, Location and Competitors
Table 43. SAP Cell and Advanced Therapies Supply Chain Management Major Business
Table 44. SAP Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 45. SAP SWOT Analysis
Table 46. SAP Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 47. SAP Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Hypertrust Patient Data Care Corporate Information, Location and Competitors
Table 49. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Major Business
Table 50. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 51. Hypertrust Patient Data Care SWOT Analysis
Table 52. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 53. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Haemonetics Corporate Information, Location and Competitors
Table 55. Haemonetics Cell and Advanced Therapies Supply Chain Management Major Business
Table 56. Haemonetics Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 57. Haemonetics SWOT Analysis
Table 58. Haemonetics Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 59. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. MasterControl Corporate Information, Location and Competitors
Table 61. MasterControl Cell and Advanced Therapies Supply Chain Management Major Business
Table 62. MasterControl Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 63. MasterControl SWOT Analysis
Table 64. MasterControl Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 65. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. TraceLink Corporate Information, Location and Competitors
Table 67. TraceLink Cell and Advanced Therapies Supply Chain Management Major Business
Table 68. TraceLink Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 69. TraceLink SWOT Analysis
Table 70. TraceLink Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 71. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. SAVSU Technologies Corporate Information, Location and Competitors
Table 73. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Major Business
Table 74. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 75. SAVSU Technologies SWOT Analysis
Table 76. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 77. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. TrakCel Corporate Information, Location and Competitors
Table 79. TrakCel Cell and Advanced Therapies Supply Chain Management Major Business
Table 80. TrakCel Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 81. TrakCel SWOT Analysis
Table 82. TrakCel Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 83. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Title21 Health Solutions Corporate Information, Location and Competitors
Table 85. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Major Business
Table 86. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 87. Title21 Health Solutions SWOT Analysis
Table 88. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 89. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. sedApta Group Corporate Information, Location and Competitors
Table 91. sedApta Group Cell and Advanced Therapies Supply Chain Management Major Business
Table 92. sedApta Group Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 93. sedApta Group SWOT Analysis
Table 94. sedApta Group Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 95. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Vineti Corporate Information, Location and Competitors
Table 97. Vineti Cell and Advanced Therapies Supply Chain Management Major Business
Table 98. Vineti Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 99. Vineti SWOT Analysis
Table 100. Vineti Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 101. Vineti Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Stafa Cellular Therapy Corporate Information, Location and Competitors
Table 103. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Major Business
Table 104. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Total Revenue (USD Million) (2017-2018)
Table 105. Stafa Cellular Therapy SWOT Analysis
Table 106. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product and Solutions
Table 107. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Players (2015-2020)
Table 109. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Players (2015-2020)
Table 110. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Regions (2015-2020)
Table 112. North America Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
Table 113. North America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Table 114. Europe Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Cell and Advanced Therapies Supply Chain Management Revenue by Countries (2015-2020)
Table 117. South America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Table 120. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) by Type (2015-2020)
Table 121. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Type (2015-2020)
Table 122. Global Cell and Advanced Therapies Supply Chain Management Revenue Forecast by Type (2021-2025)
Table 123. Global Cell and Advanced Therapies Supply Chain Management Revenue by Application (2015-2020)
Table 124. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Application (2015-2020)
Table 125. Global Cell and Advanced Therapies Supply Chain Management Revenue Forecast by Application (2021-2025)
Table 126. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell and Advanced Therapies Supply Chain Management Picture
Figure 2. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type in 2019
Figure 3. Cloud Picture
Figure 4. On-premises Picture
Figure 5. Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application in 2019
Figure 6. Biobank Picture
Figure 7. Cell Therapy Lab Picture
Figure 8. Hospital Picture
Figure 9. Research Institute Picture
Figure 10. Commercial Organization Picture
Figure 11. Global Cell and Advanced Therapies Supply Chain Management Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cell and Advanced Therapies Supply Chain Management Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cell and Advanced Therapies Supply Chain Management Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Regions in 2018
Figure 25. North America Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 28. South America Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 30. North America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries in 2019
Figure 32. USA Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries in 2019
Figure 37. Germany Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 38. UK Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 39. France Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries in 2019
Figure 44. China Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 47. India Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 49. South America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries in 2019
Figure 51. Brazil Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cell and Advanced Therapies Supply Chain Management Revenue and Growth Rate (2015-2020)
Figure 59. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Type (2015-2020)
Figure 60. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Type in 2019
Figure 61. Global Cell and Advanced Therapies Supply Chain Management Market Share Forecast by Type (2021-2025)
Figure 62. Global Cloud Revenue Growth Rate (2015-2020)
Figure 63. Global On-premises Revenue Growth Rate (2015-2020)
Figure 64. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Application (2015-2020)
Figure 65. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Application in 2019
Figure 66. Global Cell and Advanced Therapies Supply Chain Management Market Share Forecast by Application (2021-2025)
Figure 67. Global Biobank Revenue Growth Rate (2015-2020)
Figure 68. Global Cell Therapy Lab Revenue Growth Rate (2015-2020)
Figure 69. Global Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 71. Global Commercial Organization Revenue Growth Rate (2015-2020)
Figure 72. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cell and Advanced Therapies Supply Chain Management Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
Figure 76. Europe Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
Figure 78. South America Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---